FDA
-
-
-
-
-
-
-
Janux Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights
-
-
-
-
-
-
-
Janux Therapeutics to Present Preclinical Data at the 18th Annual PEGS Boston for PSMA-TRACTr and EGFR-TRACTr
-
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

